Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2720-2729

Blackwell Publishing

Access to resources Recommend Favorite

Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China

By Ji Ming-Fang   Huang Qi-Hong   Yu Xia   Liu Zhiwei   Li Xinghua   Zhang Li-Fang   Wang Panpan   Xie Shang-Hang   Rao Hui-Lan   Fang Fang   Guo Xiang   Liu Qing   Hong Ming-Huang   Ye Weimin   Zeng Yi-Xin   Cao Su-Mei  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1353-1360

Blackwell Publishing

Access to resources Recommend Favorite

Recent developments in the prevention and treatment of Epstein–Barr virus-associated lymphoproliferative diseases

By Meerbach Astrid   Gruhn Bernd   Wutzler Peter  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 527-547

Informa Healthcare

Access to resources Recommend Favorite

The role of Epstein-Barr virus–encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma

By  

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2358-2366

Blackwell Publishing

Access to resources Recommend Favorite

Lytic replication of Epstein–Barr virus

By Lu Chih-Chung   Chen Mei-Ru  

Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. : 435-446

Future Medicine

Access to resources Recommend Favorite